Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Colorcon
Julphar
Mallinckrodt
Chinese Patent Office
Cipla
McKesson
Harvard Business School
Argus Health

Generated: August 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201886

« Back to Dashboard
NDA 201886 describes VYFEMLA, which is a drug marketed by Lupin Ltd and is included in one NDA. It is available from two suppliers. Additional details are available on the VYFEMLA profile page.

The generic ingredient in VYFEMLA is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for NDA: 201886

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 201886

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VYFEMLA
ethinyl estradiol; norethindrone
TABLET;ORAL-28 201886 ANDA LUPIN LIMITED 57297-875 57297-875-13 3 POUCH in 1 CARTON (57297-875-13) > 1 BLISTER PACK in 1 POUCH (57297-875-11) > 1 KIT in 1 BLISTER PACK
VYFEMLA
ethinyl estradiol; norethindrone
TABLET;ORAL-28 201886 ANDA Lupin Pharmaceuticals, Inc. 68180-875 68180-875-13 3 POUCH in 1 CARTON (68180-875-13) > 1 BLISTER PACK in 1 POUCH (68180-875-11) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.4MG
Approval Date:Sep 26, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Fish and Richardson
Novartis
Boehringer Ingelheim
Queensland Health
UBS
Farmers Insurance
Colorcon
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot